Personalizing Medicine: Targeting Breast Cancer Cell Membrane Proteomics

One of the unpleasant survival tactics shown by cancer cells is their ability to develop resistance to previously efficacious chemotherapy. Scientists know this happens in part from kinome reprogramming, where the malignant cell increases kinase activity in enzymes unaffected by treatment, radically altering behavior and activity. When resistance occurs, oncologists switch to a broad-spectrum chemotherapy Read the rest of this article

The post Personalizing Medicine: Targeting Breast Cancer Cell Membrane Proteomics appeared first on Accelerating Science.

from http://ift.tt/1EQ1Mud
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s